Please Wait
Applying Filters...
menu
    • menu
    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Urcosimod

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    OKYO Pharma Announces Chairman And Founder Acquires Shares
    OKYO Pharma Announces Chairman And Founder Acquires Shares

    15 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/15/3205428/0/en/OKYO-Pharma-Announces-Chairman-and-Founder-Acquires-Shares.html

    GLOBENEWSWIRE
    15 Dec 2025
    Share Share
    Okoyo Pharma Reports Positive Corneal Nerve Results
    Okoyo Pharma Reports Positive Corneal Nerve Results

    11 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/11/3203917/0/en/OKYO-Pharma-Announces-New-Data-Showing-Favorable-Corneal-Nerve-Outcomes-in-Phase-2-Study-for-Neuropathic-Corneal-Pain.html

    GLOBENEWSWIRE
    11 Dec 2025
    Share Share
    OKYO Pharma Announces Chairman And Founder Acquires Shares
    OKYO Pharma Announces Chairman And Founder Acquires Shares

    21 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/21/3192792/0/en/OKYO-Pharma-Announces-Chairman-and-Founder-Acquires-Shares.html

    GLOBENEWSWIRE
    21 Nov 2025
    Share Share
    OKYO Pharma To Present At OIS XV In San Diego
    OKYO Pharma To Present At OIS XV In San Diego

    18 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/18/3190029/0/en/OKYO-Pharma-to-Present-at-OIS-XV-in-San-Diego.html

    GLOBENEWSWIRE
    18 Nov 2025
    Share Share
    Okoyo Pharma Initiates 100-Patient Trial For Urcosimod
    Okoyo Pharma Initiates 100-Patient Trial For Urcosimod

    22 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/22/3153922/0/en/OKYO-Pharma-Announces-Registration-Pathway-with-100-Patient-Multi-Center-Clinical-Trial-of-Urcosimod-in-Neuropathic-Corneal-Pain.html

    GLOBENEWSWIRE
    22 Sep 2025
    Share Share
    OKYO Pharma's Phase 2 Results for Urcosimod in Corneal Pain
    OKYO Pharma's Phase 2 Results for Urcosimod in Corneal Pain

    16 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/16/3116513/0/en/OKYO-Pharma-Unveils-Strong-Phase-2-Clinical-Trial-Results-for-Urcosimod-to-Treat-Neuropathic-Corneal-Pain.html

    GLOBENEWSWIRE
    16 Jul 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.